Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2016
Price : $35 *
At a glance
- Drugs Carteolol/latanoprost (Primary) ; Carteolol; Latanoprost
- Indications Glaucoma; Ocular hypertension
- Focus Pharmacokinetics
- Sponsors Otsuka Pharmaceutical
- 12 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrial.gov record.
- 07 Jul 2014 Planned End Date changed from 1 May 2014 to 1 Oct 2014 as reported by ClinicalTrial.gov.
- 07 Jul 2014 Planned primary completion date changed from 1 May 2014 to 1 Oct 2014 as reported by ClinicalTrial.gov.